Michael Steel

881 total citations
23 papers, 563 citations indexed

About

Michael Steel is a scholar working on Genetics, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michael Steel has authored 23 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Oncology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michael Steel's work include BRCA gene mutations in cancer (7 papers), Global Cancer Incidence and Screening (3 papers) and Pelvic floor disorders treatments (3 papers). Michael Steel is often cited by papers focused on BRCA gene mutations in cancer (7 papers), Global Cancer Incidence and Screening (3 papers) and Pelvic floor disorders treatments (3 papers). Michael Steel collaborates with scholars based in United Kingdom, Switzerland and France. Michael Steel's co-authors include Gary G. Kay, Ludmyla Rekeda, Ursula Ebinger, Thomas H. Crook, Judith Evans, John J. Miles, K. Lheritier, Peter Dwyer, Adrian L. Harris and Angela Cox and has published in prestigious journals such as Cell, The Lancet and European Urology.

In The Last Decade

Michael Steel

22 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Steel United Kingdom 11 254 228 168 68 66 23 563
Mark Plante United States 20 692 2.7× 400 1.8× 97 0.6× 105 1.5× 116 1.8× 49 1.4k
Keith Van Arsdalen United States 13 241 0.9× 143 0.6× 25 0.1× 142 2.1× 51 0.8× 30 665
G. Lunglmayr Austria 18 154 0.6× 128 0.6× 23 0.1× 157 2.3× 63 1.0× 80 837
Giuseppe Fallara Italy 18 134 0.5× 152 0.7× 36 0.2× 198 2.9× 148 2.2× 120 1.0k
Erica D. Dommasch United States 14 44 0.2× 229 1.0× 114 0.7× 77 1.1× 52 0.8× 29 989
Nicola Frego Italy 17 116 0.5× 45 0.2× 58 0.3× 143 2.1× 83 1.3× 63 652
Vernon F. Schabert United States 13 39 0.2× 201 0.9× 91 0.5× 24 0.4× 52 0.8× 30 461
Hartwig Büttner Germany 18 310 1.2× 61 0.3× 39 0.2× 150 2.2× 139 2.1× 53 1.0k
Whi‐An Kwon South Korea 12 83 0.3× 63 0.3× 67 0.4× 70 1.0× 107 1.6× 47 430
Henrikki Santti Finland 13 46 0.2× 33 0.1× 38 0.2× 178 2.6× 147 2.2× 25 603

Countries citing papers authored by Michael Steel

Since Specialization
Citations

This map shows the geographic impact of Michael Steel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Steel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Steel more than expected).

Fields of papers citing papers by Michael Steel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Steel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Steel. The network helps show where Michael Steel may publish in the future.

Co-authorship network of co-authors of Michael Steel

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Steel. A scholar is included among the top collaborators of Michael Steel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Steel. Michael Steel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Härmark, Linda, et al.. (2021). Online information discrepancies regarding safety of medicine use during pregnancy and lactation: an IMI ConcePTION study. Expert Opinion on Drug Safety. 20(9). 1117–1124. 14 indexed citations
2.
Steel, Michael, David Goudie, Frank Sullivan, et al.. (2014). Why do women not return family history forms when referred to breast cancer genetics services? A mixed‐method study. Health Expectations. 18(5). 1735–1743. 1 indexed citations
3.
Pasanisi, Patrizia, Guy Hédelin, Jenny Chang‐Claude, et al.. (2009). Oral Contraceptive Use and BRCA Penetrance: A Case-Only Study. Cancer Epidemiology Biomarkers & Prevention. 18(7). 2107–2113. 16 indexed citations
4.
Abrams, Paul, Con Kelleher, Jasper Huels, et al.. (2008). Clinical relevance of health‐related quality of life outcomes with darifenacin. British Journal of Urology. 102(2). 208–213. 21 indexed citations
5.
Thompson, Alastair M., Keith Brennan, Angela Cox, et al.. (2008). Evaluation of the current knowledge limitations in breast cancer research: a gap analysis. Breast Cancer Research. 10(2). R26–R26. 85 indexed citations
6.
Hill, Simon, Mostafa Elhilali, R. J. Millard, et al.. (2007). Long-term darifenacin treatment for overactive bladder in patients aged 65 years and older: analysis of results from a 2-year, open-label extension study. Current Medical Research and Opinion. 23(11). 2697–2704. 26 indexed citations
7.
Young, Dorothy C., David Goudie, Alan Cook, et al.. (2006). Analysis of referrals to a multi-disciplinary breast cancer genetics clinic: practical and economic considerations. Familial Cancer. 5(4). 297–303. 8 indexed citations
8.
Özakinci, Gözde, Gerry Humphris, & Michael Steel. (2006). Provision of Breast Cancer Risk Information to Women at the Lower End of the Familial Risk Spectrum. Public Health Genomics. 10(1). 41–44. 1 indexed citations
9.
Haab, François, Jacques Corcos, Paul Siami, et al.. (2006). Long‐term treatment with darifenacin for overactive bladder: results of a 2‐year, open‐label extension study. British Journal of Urology. 98(5). 1025–1032. 38 indexed citations
10.
Kay, Gary G., et al.. (2006). Differential Effects of the Antimuscarinic Agents Darifenacin and Oxybutynin ER on Memory in Older Subjects. European Urology. 50(2). 317–326. 208 indexed citations
11.
Steel, Michael. (2005). Molecular Medicine: Promises, Promises?. Journal of the Royal Society of Medicine. 98(5). 197–199. 1 indexed citations
12.
Steel, Michael. (2002). Book of the Month: The Common Thread: A Story of Science, Ethics and the Human Genome. Journal of the Royal Society of Medicine. 95(8). 420–421. 2 indexed citations
13.
Steel, Michael, Elizabeth Smyth, Hans F. A. Vasen, et al.. (1999). Ethical, Social and Economic Issues in Familial Breast Cancer: A Compilation of Views from the E.C. Biomed II Demonstration Project. Disease Markers. 15(1-3). 125–131. 19 indexed citations
14.
Steel, Michael. (1999). Altered Genes: Reconstructing Nature: the Debate. Journal of the Royal Society of Medicine. 92(10). 540–541. 14 indexed citations
15.
Steel, Michael. (1998). Hormones and Cancer: Breast/Ovarian Cancer and Genetic Susceptibility. Journal of Nutritional & Environmental Medicine. 8(2). 169–176. 1 indexed citations
16.
Steel, Michael. (1997). The Troubled Helix: Social and Psychological Implications. Journal of the Royal Society of Medicine. 90(3). 175–176. 1 indexed citations
17.
Steel, Michael. (1995). Telomerase that shapes our ends. The Lancet. 345(8955). 935–936. 8 indexed citations
18.
Old, Robert, et al.. (1993). HETEROZYGOTE ADVANTAGE. The Lancet. 341(8839). 214–214. 1 indexed citations
19.
Steel, Michael. (1988). IVth INTERNATIONAL AIDS CONFERENCE. The Lancet. 332(8601). 54–55. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026